TCL Archive “Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers April 17, 1981
TCL Archive In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell February 4, 1977
TCL Archive After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant July 11, 2014
TCL Archive Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent. February 24, 2006
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005